|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 213/12 | |
| C07D 213/69 | |||
| C07D 213/78 | |||
| C07D 401/06 |
| (11) | Number of the document | 3077376 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14866855.1 |
| Date of filing the European patent application | 2014-12-02 | |
| (97) | Date of publication of the European application | 2016-10-12 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/068008 |
| Date | 2014-12-02 |
| (87) | Number | WO 2015/084763 |
| Date | 2015-06-11 |
| (30) | Number | Date | Country code |
| 201361911686 P | 2013-12-04 | US | |
| 201462017542 P | 2014-06-26 | US |
| (72) |
CAO, Yang, US
GAUTHIER, Donald R. Jr., US
HUMPHREY, Guy R., US
ITOH, Tetsuji, US
JOURNET, Michel, US
QIAN, Gang, US
SHERRY, Benjamin D., US
TSCHAEN, David M., US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | PROCESS FOR MAKING REVERSE TRANSCRIPTASE INHIBITORS |
| PROCESS FOR MAKING REVERSE TRANSCRIPTASE INHIBITORS |